CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Made donor cells aim to beat cancer without the side effects
Disease control OngoingThis study is for children and young adults up to age 21 with high-risk blood cancers like leukemia or lymphoma. It tests a transplant using specially treated donor cells from a family member to reduce the risk of the cancer coming back while lowering the chance of a serious side…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Malaria drug may boost leukemia treatment in new trial
Disease control OngoingThis study tests whether adding artesunate (a malaria drug) to the standard leukemia medicine imatinib can improve outcomes for people with chronic myeloid leukemia (CML). About 75 adults with newly diagnosed or poorly responding CML will receive either imatinib alone or imatinib…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Obafemi Awolowo University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC